C9ORF93 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.5848992925055E-11 |
Normal-vs-Stage2 |
4.06039646350109E-11 |
Normal-vs-Stage3 |
1.62714286489063E-12 |
Normal-vs-Stage4 |
1.62481139653892E-12 |
Stage1-vs-Stage2 |
1.399360E-01 |
Stage1-vs-Stage3 |
1.637360E-04 |
Stage1-vs-Stage4 |
2.27159999999227E-05 |
Stage2-vs-Stage3 |
1.275180E-01 |
Stage2-vs-Stage4 |
3.586000E-02 |
Stage3-vs-Stage4 |
3.629800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
8.00279997825726E-09 |
Normal-vs-Asian |
5.637900E-02 |
Caucasian-vs-AfricanAmerican |
7.479000E-01 |
Caucasian-vs-Asian |
2.616400E-01 |
AfricanAmerican-vs-Asian |
3.463400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.37587727269783E-14 |
Normal-vs-Female |
1.51729995234717E-09 |
Male-vs-Female |
7.742000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.15340000003983E-06 |
Normal-vs-Age(41-60Yrs) |
2.60935717477651E-12 |
Normal-vs-Age(61-80Yrs) |
1.6269208202857E-12 |
Normal-vs-Age(81-100Yrs) |
2.35629999999487E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.019800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.917800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.811800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.626400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.353800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.830800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.529600E-02 |
Normal-vs-Grade 2 |
1.05989994558797E-09 |
Normal-vs-Grade 3 |
1.63935531816151E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
4.830200E-01 |
Grade 1-vs-Grade 3 |
7.446400E-02 |
Grade 1-vs-Grade 4 |
1.175730E-02 |
Grade 2-vs-Grade 3 |
4.380500E-04 |
Grade 2-vs-Grade 4 |
3.6103999789816E-09 |
Grade 3-vs-Grade 4 |
1.061600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.01319996836935E-09 |
Normal-vs-ccB subtype |
2.7654545320388E-12 |
ccA subtype-vs-ccB subtype |
1.354410E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.67010849594362E-12 |
Normal-vs-N1 |
9.24220000531051E-09 |
N0-vs-N1 |
6.309800E-02 |
|
|